Industry & Research Insights

L7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration

The Result Is An Automated, Highly Efficient, and Cost Effective Lab Management Process This month’s “Company Spotlight” provides a closer look at L7 Informatics, the provider of a scientific process and data management...read more

A Complete Y chromosome Sequence – Represents over 180,000 Years of Evolution of the Human Y Sequence

While the first reference human genome is more than 20 years old (Skaletsky et al, 2003), the reference human genome GRCh38 Y chromosome was missing almost half of its 57.2 Mb. But the August 23 online publication of...read more

Changing the Clinical Genetic Testing Paradigm to Increase Sensitivity and Specificity

The goal of clinical genomics is to provide a diagnosis for difficult-to-solve inherited and somatic disorders to enhance a personalized therapeutic approach. Unfortunately, despite costly and extensive testing only...read more

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

We may still be five Years out until We Can Sequence Everyone I had the chance to attend the Precision Medicine World Conference PMWC 2023 SV in the last couple of days. Some 2,000+ individuals from across the life...read more

Goodbye 2022 – Hello 2023

We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more

ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists

This month’s “Company Spotlight” provides a closer look at ONTOFORCE, the creator of a semantic search technology platform for insight generation. I spoke with Valerie Morel, CEO of ONTOFORCE, about ONTOFORCE’s platform...read more

UK GENOMICS SPOTLIGHT Report: LEADING INNOVATIONS 2022

Time Is What We Want Most – Why Wasting Any More of It?

As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more

Omicron NTD Insertions: A new Route for Variant Generation?

My most recent article published was a quick review of what was known about the SARS Omicron variant in the post 2021, The Year of the Various SARS-CoV-2 Variants of Concern – from Alpha to Omicron. While researching...read more

Deepcell Aims to Create a Single Cell Morpholome Platform

This month’s “Company Spotlight” takes a closer look at Deepcell, a company that is building a platform for the identification, isolation, and classification of viable cells based on their morphological distinctions for...read more

We Invite you to join enlightenbio’s Subject Matter Expert Network!

enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more

Truwl is on a Mission to Make Bioinformatics Comprehensible and Accessible

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio LLC product offering. This new report provides insights into...read more

Features & Insights

Invaluable insights into critical developments in life science and clinical research. Discussions of new products and companies, reviews of scientific conferences and recent innovations. Development opportunities in the area of diagnostics and genetics.

Features and insights